Saturday 17 October 2026
Export NCEL’s income statement to Excel — free account
NewcelX Ltd.
NCEL Healthcare Biotechnology
Insiders bought in the last twelve months.
2.50
0.35
−12.28%
Follow NCEL
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
0.76 | 0.09 | 0.23 | 2.75 | 2.38 | 0.03 | 0.09 | 0.04 | — |
Net Debt/EBITDA |
0.74 | (4.28) | (0.06) | 0.58 | 0.46 | (0.63) | (0.02) | (2.05) | — |
Debt/Assets |
3.10% | 855.59% | 88.47% | 0.00% | 0.00% | 123.23% | 43.38% | 4,871.70% | 0.00% |
Debt/Equity |
0.05 | (0.97) | (0.18) | 0.00 | 0.00 | (0.17) | (0.05) | (0.80) | — |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.33 | 0.15 | 0.80 | 0.84 | 1.25 | 0.25 | 0.03 | 0.53 | — |
Capex/Depreciation |
(0.15) | (0.01) | 0.00 | 0.00 | (0.77) | 0.00 | 0.00 | — | — |
Interest Coverage |
(0.43) | (0.41) | (98.47) | (162.63) | (246.58) | (26.49) | (4,197.00) | (6.27) | — |
| 2,225.20% | 85.53% | 438.41% | (862.93%) | 283.03% | 37.76% | 72.70% | 68.69% | — | |
| (134.43%) | (523.49%) | (218.86%) | (219.34%) | (342.48%) | (299.94%) | (1,293.85%) | (7,069.78%) | — | |
ROIC |
(29.63%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Return on Tangible Assets |
904.14% | 90.01% | 199.88% | (279.36%) | (356.69%) | 40.84% | 149.10% | 221.41% | — |
Average Days of Receivables |
— | — | — | — | — | — | 0.00 | 0.00 | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Intangible Assets out of Total Assets |
0.71 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | — | — | — | — | — |
Free Cash Flow per Share |
(0.72) | (0.36) | (101.51) | (282.10) | (502.54) | (41.92) | (11.11) | (0.25) | — |
Cash per Share |
0.57 | 0.22 | 9.41 | 181.88 | 182.26 | 5.39 | 12.88 | 0.00 | — |
Shareholders Equity per Share |
1.89 | (2.70) | (92.60) | 66.68 | 18.20 | (516.33) | (360.88) | (0.79) | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
1.89 | (2.70) | (92.60) | 66.68 | 18.20 | (516.33) | (360.88) | (0.79) | — |
Free Cash Flow |
(2.77) | (1.07) | (9.68) | (13.88) | (14.98) | (0.73) | (0.19) | (2.73) | — |
Working Capital |
(1.01) | (8.12) | (6.10) | 5.89 | 3.32 | (7.01) | (3.65) | (2.32) | — |
Capital Expenditures |
(0.01) | (0.01) | — | — | (0.04) | — | — | — | — |
Net Current Asset Value |
(1.01) | (8.12) | (8.86) | 3.25 | 0.50 | (10.00) | (6.49) | (8.87) | — |
| Other line items | |||||||||
Quick Ratio |
0.52 | 0.07 | 0.11 | 2.66 | 2.26 | 0.01 | 0.05 | 0.01 | — |
Depreciation/Fixed assets |
0.58 | 3.36 | 1.70 | 4.33 | 1.75 | 0.00 | 0.00 | — | — |
Cash ROIC |
(28.29%) | (282.11%) | 153.67% | (113.49%) | (250.70%) | 9.86% | 3.36% | 159.46% | — |
Accounts Receivable Turnover |
— | — | — | — | — | — | 0.00 | 0.00 | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | — | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | — | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF per Share |
(0.72) | (0.36) | (101.51) | (282.10) | (501.21) | (41.92) | (11.11) | (0.25) | — |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | (1.33) | 0.00 | 0.00 | 0.00 | — |
Average Receivables |
— | — | — | — | — | — | 0.04 | 0.04 | — |
Average Payables |
1.67 | 2.90 | 3.50 | 2.06 | 2.87 | 3.26 | 1.82 | 1.82 | — |
Average Assets |
6.17 | 1.37 | 5.56 | 7.52 | 3.49 | 0.95 | 0.42 | 0.07 | — |
Average Common Equity |
(0.37) | (8.41) | (2.78) | 1.91 | (4.22) | (7.58) | (7.49) | (7.49) | — |
Capex to Sales |
0.00 | 0.00 | — | — | 0.00 | — | — | — | — |
Columns are period end dates